Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
20.71
+0.95 (4.81%)
At close: May 12, 2025, 4:00 PM
20.31
-0.40 (-1.93%)
After-hours: May 12, 2025, 4:13 PM EDT
Tectonic Therapeutic Employees
Tectonic Therapeutic had 51 employees as of December 31, 2024. The number of employees increased by 7 or 15.91% compared to the previous year.
Employees
51
Change (1Y)
7
Growth (1Y)
15.91%
Revenue / Employee
n/a
Profits / Employee
-$1,150,333
Market Cap
386.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | 7 | 15.91% |
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TECX News
- 4 days ago - Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 19 days ago - Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha
- 7 weeks ago - Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data - Seeking Alpha
- 3 months ago - Tectonic Announces $185 Million Private Placement - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF - GlobeNewsWire
- 4 months ago - Tectonic Therapeutic: Protein Engineering Platform For GPCRs - Seeking Alpha
- 5 months ago - Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - GlobeNewsWire